The Long-Acting Phenothiazines
- 1 July 1975
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 32 (7) , 893-900
- https://doi.org/10.1001/archpsyc.1975.01760250085009
Abstract
Injected intramuscularly, the enanthate and decanoate esters of the phenothiazine fluphenazine are an effective treatment of the disordered behavior and thinking of schizophrenia. The decanoate preparation is not only slightly longer-acting but also has a smaller incidence of side-effects than the enanthate. The major adverse effect of these medications is the high frequency of extrapyramidal system disturbance. Since the 50% rate of failure of schizophrenic outpatients to take prescribed oral medications decreases treatment failure to about 20% with the use of long-acting injectable phenothiazines, this route of administration offers an advantage in patient management particularly applicable to community mental health systems. Moreover, parenteral administration of long-acting fluphenazine may be useful for patients who do not attain effective serum levels with medication taken orally because of metabolic or absorption difficulties.Keywords
This publication has 61 references indexed in Scilit:
- Drug defaulting by patients on long-acting phenothiazinesPsychological Medicine, 1973
- Why a Long-Acting Neuroleptic? Fluphenazine DecanoatePsychosomatics, 1971
- Dangers of FluphenazineThe British Journal of Psychiatry, 1970
- Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing MedicationThe British Journal of Psychiatry, 1969
- Fluphenazine Enanthate and Fluphenazine Decanoate: A Comparative Study in Chronic Schizophrenic OutpatientsPsychosomatics, 1969
- Fluphenazine enanthate and schizophrenia.BMJ, 1969
- A Controlled Trial of Fluphenazine Enanthate in Hospitalized Chronic SchizophrenicsThe British Journal of Psychiatry, 1968
- Maintenance Treatment of Schizophrenic Outpatients With a Depot PhenothiazinePsychosomatics, 1968
- Estimation of Drug Rejection by Schizophrenic In-Patients, with Analysis of Clinical FactorsThe British Journal of Psychiatry, 1967
- Patient co-operation and the sensitivity of clinical trialsJournal of Chronic Diseases, 1962